FDA approves IDE application to initiate Tryton Side Branch Stent System for coronary artery disease
Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced U.S. Food and Drug Administration (FDA) conditional approval for an Investigational Device Exemption (IDE) application to initiate the pivotal trial to evaluate the Tryton Side Branch Stent System for the treatment of coronary artery disease.
|
|
Advances in Laserology – Selected Papers of Laser Florence 2010:: The 50th Birthday of Laser Medicine World (AIP Conference Proceedings / Atomic, Molecular, Chemical Physics) $98.17 Laser Florence 2010 is the annual Congress of the International Academy Laser Medicine and Surgery. The year 2010 is the fiftieth birthday of Laser and we celebrated it with a special edition. As usual researchers and doctors were shown new data immediately available for practical use, in different topics: Dentistry, Dermatology, Neurology, Rehabilitation and Sport Injuries, ENT, Phlebology, Pla… |
|
|
Laser Florence 2009: A Gallery Through the Laser Medicine World (AIP Conference Proceedings) $80.58 Laser Florence 2009 would like to be a bridge between scientists under the umbrella of the International Academy Laser Medicine and Surgery, www.ialms.com . The enthusiasm of young researchers and doctors could be driven towards new data selected by some pioneers of this matter and immediately available for practical use…. |